SELLAS Life Sciences Group, Inc. Common Stock SLS
$11.88
-4.27%
at last close
Analyst Consensus
- Consensus Rating
- Buy (1 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $10.00
- Implied Upside
- -15.8%
- Price Target Range
- $10.00 – $10.00
- Analysts (12 mo)
- 1
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-03-12 | Maxim GroupJason McCarthy |
Maintains | Buy | $7 → $10 |
| 2025-07-16 | Maxim GroupJason McCarthy |
Maintains | Buy | $4 → $7 |
| 2023-11-22 | Cantor FitzgeraldLi Watsek |
Reiterates | Overweight | $3 |
| 2023-09-07 | Cantor FitzgeraldLi Watsek |
Reiterates | Overweight | $3 |
| 2022-11-15 | Alliance Global PartnersJames Molloy |
Maintains | Buy | $14 → $8 |
| 2022-06-28 | Cantor FitzgeraldLi Watsek |
Maintains | Overweight | $10 → $6 |
| 2021-07-21 | Cantor FitzgeraldLi Watsek |
Initiates coverage on | Overweight | $18 |
| 2019-11-15 | Maxim GroupJason McCarthy |
Upgrades | Hold → Buy | $12 |
| 2019-04-08 | Alliance Global Partners |
Initiates coverage on | Buy | $225 |
| 2018-11-01 | OppenheimerHartaj Singh |
Initiates coverage on | Outperform | $650 |
| 2018-07-20 | Maxim GroupJason McCarthy |
Maintains | Buy | $650 → $250 |
| 2018-04-02 | HC Wainwright & Co. |
Initiates coverage on | Buy | $550 |
| 2018-03-19 | Maxim GroupJason McCarthy |
Upgrades | Hold → Buy | — |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $11.88
- Market Cap
- $2.51 billion
- 52-Week Range
- $1.39 – $15.88
- Average Volume
- 5.78 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.